Literature DB >> 25025694

Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome.

Sam Kafian1, Fariborz Mobarrez, Håkan Wallén, Bassem Samad.   

Abstract

High on-treatment platelet reactivity (HPR) to clopidogrel has been shown to increase the risk of cardiovascular events. Platelet-derived microvesicles (PMVs) may be prothrombotic and contribute to the risk of recurrent events observed in patients with HPR. However, PMVs may also serve as biomarkers and be used to assess platelet function. We investigated the association between platelet responses to clopidogrel (measured by whole blood impedance aggregometry) and circulating PMVs in patients with acute coronary syndrome (ACS). Blood samples were obtained at discharge from 200 patients with ACS who had undergone percutaneous coronary intervention (PCI). All patients were loaded with aspirin and clopidogrel before PCI. ADP-induced whole blood impedance aggregometry and measurement of PMVs were performed. Cut-off values for HPR and other reactivity (i.e. normal on-treatment reactivity, NPR and low on-treatment reactivity, LPR) to clopidogrel were set according to data from large prospective studies. We measured PMVs as phosphatidylserine and CD42a positive vesicles, together with CD62P or CD40L, using flow cytometry. ADP-induced platelet aggregation revealed that approximately 20% of patients had HPR. Levels of PMVs were almost two-fold higher in the HPR group compared with patients without HPR (for both CD42a- and CD62P-positive PMVs, p < 0.01). Furthermore, patients with LPR to clopidogrel had significantly fewer PMVs exposing CD62P than patients with HPR or those with NPR to clopidogrel. Patients with HPR during clopidogrel treatment have elevated levels of circulating PMVs, indicating ongoing platelet activation despite clopidogrel treatment. Moreover, in patients with LPR to clopidogrel, circulating PMV numbers are decreased. Taken together, our data suggest that PMVs are potential biomarkers of antiplatelet responses to clopidogrel. If PMVs also have prognostic value after, ACS should be tested in future studies.

Entities:  

Keywords:  Acute coronary syndrome; clopidogrel; multiple electrode aggregometry; platelet-derived microvesicles; platelets

Mesh:

Substances:

Year:  2014        PMID: 25025694     DOI: 10.3109/09537104.2014.940304

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  8 in total

1.  Diurnal variation of circulating microvesicles is associated with the severity of obstructive sleep apnoea.

Authors:  András Bikov; László Kunos; Éva Pállinger; Zsófia Lázár; Adrián Kis; Gábor Horváth; György Losonczy; Zsolt István Komlósi
Journal:  Sleep Breath       Date:  2017-01-27       Impact factor: 2.816

2.  Flow analysis of individual blood extracellular vesicles in acute coronary syndrome.

Authors:  Murad Vagida; Anush Arakelyan; Anna Lebedeva; Jean-Charles Grivel; Alexander Shpektor; Elena Vasilieva; Leonid Margolis
Journal:  Platelets       Date:  2016-09-05       Impact factor: 3.862

3.  Analysis of Extracellular Vesicles Using Magnetic Nanoparticles in Blood of Patients with Acute Coronary Syndrome.

Authors:  M S Vagida; A Arakelyan; A M Lebedeva; J-Ch Grivel; A V Shpektor; E Yu Vasilieva; L B Margolis
Journal:  Biochemistry (Mosc)       Date:  2016-04       Impact factor: 2.487

Review 4.  The Function and Regulation of Platelet P2Y12 Receptor.

Authors:  Xiaohua Li; Guoxing Zhang; Xia Cao
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-28       Impact factor: 3.727

5.  Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel.

Authors:  Aleksandra Gasecka; Rienk Nieuwland; Monika Budnik; Françoise Dignat-George; Ceren Eyileten; Paul Harrison; Romaric Lacroix; Aurélie Leroyer; Grzegorz Opolski; Kinga Pluta; Edwin van der Pol; Marek Postuła; Pia Siljander; Jolanta M Siller-Matula; Krzysztof J Filipiak
Journal:  J Thromb Haemost       Date:  2020-01-09       Impact factor: 5.824

6.  Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Xiuying Tang; Runjun Li; Quanmin Jing; Yingfeng Liu; Peng Liu
Journal:  PLoS One       Date:  2015-06-11       Impact factor: 3.240

Review 7.  The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles.

Authors:  Justyna Rosińska; Maria Łukasik; Wojciech Kozubski
Journal:  Cardiovasc Drugs Ther       Date:  2017-12       Impact factor: 3.727

8.  Changes in the plasma microvesicle proteome during the ovarian hyperstimulation phase of assisted reproductive technology.

Authors:  Nina Olausson; Fariborz Mobarrez; Roman Zubarev; Alexey Chernobrovkin; Dorothea Rutishauser; Katarina Bremme; Eli Westerlund; Outi Hovatta; Håkan Wallén; Peter Henriksson
Journal:  Sci Rep       Date:  2020-08-12       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.